Literature DB >> 26446877

Perforin facilitates beta cell killing and regulates autoreactive CD8+ T-cell responses to antigen in mouse models of type 1 diabetes.

Prerak Trivedi1,2, Kate L Graham1,2, Balasubramaninan Krishnamurthy1,2, Stacey Fynch1, Robyn M Slattery3, Thomas W H Kay1,2, Helen E Thomas1,2.   

Abstract

In type 1 diabetes, cytotoxic CD8(+) T lymphocytes (CTLs) directly interact with pancreatic beta cells through major histocompatibility complex class I. An immune synapse facilitates delivery of cytotoxic granules, comprised mainly of granzymes and perforin. Perforin deficiency protects the majority of non-obese diabetic (NOD) mice from autoimmune diabetes. Intriguingly perforin deficiency does not prevent diabetes in CD8(+) T-cell receptor transgenic NOD8.3 mice. We therefore investigated the importance of perforin-dependent killing via CTL-beta cell contact in autoimmune diabetes. Perforin-deficient CTL from NOD mice or from NOD8.3 mice were significantly less efficient at adoptive transfer of autoimmune diabetes into NODRag1(-/-) mice, confirming that perforin is essential to facilitate beta cell destruction. However, increasing the number of transferred in vitro-activated perforin-deficient 8.3 T cells reversed the phenotype and resulted in diabetes. Perforin-deficient NOD8.3 T cells were present in increased proportion in islets, and proliferated more in response to antigen in vivo indicating that perforin may regulate the activation of CTLs, possibly by controlling cytokine production. This was confirmed when we examined the requirement for direct interaction between beta cells and CD8(+) T cells in NOD8.3 mice, in which beta cells specifically lack major histocompatibility complex (MHC) class I through conditional deletion of β2-microglobulin. Although diabetes was significantly reduced, 40% of these mice developed diabetes, indicating that NOD8.3 T cells can kill beta cells in the absence of direct interaction. Our data indicate that although perforin delivery is the main mechanism that CTL use to destroy beta cells, they can employ alternative mechanisms to induce diabetes in a perforin-independent manner.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26446877     DOI: 10.1038/icb.2015.89

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  33 in total

1.  CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.

Authors:  I F Hermans; D S Ritchie; J Yang; J M Roberts; F Ronchese
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

Review 2.  Strength of TCR-peptide/MHC interactions and in vivo T cell responses.

Authors:  Emily Corse; Rachel A Gottschalk; James P Allison
Journal:  J Immunol       Date:  2011-05-01       Impact factor: 5.422

3.  Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.

Authors:  J A Shizuru; C Taylor-Edwards; B A Banks; A K Gregory; C G Fathman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

4.  An indirect role for NK cells in a CD4(+) T-cell-dependent mouse model of type I diabetes.

Authors:  Eveline Angstetra; Kate L Graham; Yuxing Zhao; Allison E Irvin; Lorraine Elkerbout; Pere Santamaria; Robyn M Slattery; Thomas W Kay; Helen E Thomas
Journal:  Immunol Cell Biol       Date:  2011-03-08       Impact factor: 5.126

5.  In vivo effects of cytokines on pancreatic beta-cells in models of type I diabetes dependent on CD4(+) T lymphocytes.

Authors:  Eveline Angstetra; Kate L Graham; Sarah Emmett; Nadine L Dudek; Rima Darwiche; Rochelle Ayala-Perez; Janette Allison; Pere Santamaria; Thomas W H Kay; Helen E Thomas
Journal:  Immunol Cell Biol       Date:  2008-11-18       Impact factor: 5.126

6.  Autoreactive T cells induce necrosis and not BCL-2-regulated or death receptor-mediated apoptosis or RIPK3-dependent necroptosis of transplanted islets in a mouse model of type 1 diabetes.

Authors:  Yuxing Zhao; Nicholas A Scott; Stacey Fynch; Lorraine Elkerbout; W Wei-Lynn Wong; Kylie D Mason; Andreas Strasser; David C Huang; Thomas W H Kay; Helen E Thomas
Journal:  Diabetologia       Date:  2014-10-10       Impact factor: 10.122

7.  Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes.

Authors:  Jonathan Chee; Hyun-Ja Ko; Ania Skowera; Gaurang Jhala; Tara Catterall; Kate L Graham; Robyn M Sutherland; Helen E Thomas; Andrew M Lew; Mark Peakman; Thomas W H Kay; Balasubramanian Krishnamurthy
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

8.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

9.  Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time.

Authors:  Misty R Jenkins; Jesse A Rudd-Schmidt; Jamie A Lopez; Kelly M Ramsbottom; Stuart I Mannering; Daniel M Andrews; Ilia Voskoboinik; Joseph A Trapani
Journal:  J Exp Med       Date:  2015-03-02       Impact factor: 14.307

10.  Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforin.

Authors:  Julie A Spicer; Gersande Lena; Dani M Lyons; Kristiina M Huttunen; Christian K Miller; Patrick D O'Connor; Matthew Bull; Nuala Helsby; Stephen M F Jamieson; William A Denny; Annette Ciccone; Kylie A Browne; Jamie A Lopez; Jesse Rudd-Schmidt; Ilia Voskoboinik; Joseph A Trapani
Journal:  J Med Chem       Date:  2013-11-19       Impact factor: 7.446

View more
  4 in total

Review 1.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

Review 2.  T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.

Authors:  Adam L Burrack; Tijana Martinov; Brian T Fife
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-05       Impact factor: 5.555

Review 3.  The etiology and pathogenesis of type 1 diabetes - A personal, non-systematic review of possible causes, and interventions.

Authors:  Karsten Buschard
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

4.  CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation.

Authors:  Melanie R Shapiro; Wen-I Yeh; Joshua R Longfield; John Gallagher; Caridad M Infante; Sarah Wellford; Amanda L Posgai; Mark A Atkinson; Martha Campbell-Thompson; Scott M Lieberman; David V Serreze; Aron M Geurts; Yi-Guang Chen; Todd M Brusko
Journal:  Front Immunol       Date:  2020-09-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.